Mupirocine Eg

Mupirocin, the active ingredient in Mupirocine Eg, is an antibiotic presented as a topical preparation for skin application. It treats localized bacterial skin infections such as impetigo and secondary infections caused by susceptible organisms. GNH USA supplies Mupirocine Eg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mupirocin is a topical antibacterial used to manage infections of the skin and superficial tissues. - Impetigo: eradicates the causative Staphylococcus aureus or Streptococcus pyogenes, reducing lesions and contagion. - Secondary bacterial skin infections: treats infected eczema, dermatitis or wounds, limiting bacterial spread. - Minor cuts, abrasions and superficial burns colonised by susceptible bacteria: promotes healing by eliminating local infection.

Mupirocin is generally well tolerated when applied to intact skin, but local reactions can occur.

Common Side Effects: - Application site irritation: mild redness or discomfort at the site of use. - Itching or burning sensation during or after application. - Dryness or flaking of the treated skin. - Mild pain or tenderness at the application area. - Erythema or mild swelling.

Serious or Rare Side Effects: - Allergic contact dermatitis: rash, swelling, or hives beyond the application site. - Severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Systemic absorption leading to neutropenia or other blood dyscrasias (rare). - Secondary infection with resistant organisms. - Anaphylaxis (extremely rare).

Before using Mupirocine Eg, consider the following safety measures. - Apply only to the affected area: avoid use on large body surfaces or intact skin without infection. - Do not cover with occlusive dressings unless directed by a healthcare professional. - Monitor infection: discontinue and seek medical advice if signs of worsening infection appear. - Avoid use in patients with known hypersensitivity to mupirocin or other topical antibiotics. - Use with caution in immunocompromised individuals or those with extensive skin disease. - Store at room temperature: keep in the original container, protect from moisture and direct heat.

Mupirocin has limited systemic interactions, but certain co‑applications may affect safety or efficacy.

Major Interactions (Avoid): - Concurrent use of multiple topical antibiotics on the same site: may increase local irritation or resistance risk.

Moderate Interactions (Monitor Closely): - Co‑application with topical corticosteroids: can mask signs of infection progression. - Use with wound dressings containing silver or iodine: may alter drug absorption. - Systemic antibiotics targeting the same organisms: may reduce the need for topical therapy. - Application on skin pre‑treated with chemical peels or abrasive agents: may increase irritation.